Wells Fargo’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $86.6M | Sell |
1,081,271
-581
| -0.1% | -$47.9K | 0.02% | 691 |
|
|
2025
Q4 | $92.2M | Buy |
1,081,852
+234,983
| +28% | +$19.3M | 0.02% | 646 |
|
|
2025
Q3 | $65.9M | Sell |
846,869
-64,237
| -7% | -$5.02M | 0.01% | 778 |
|
|
2025
Q2 | $71.3M | Buy |
911,106
+45,487
| +5% | +$3.39M | 0.01% | 703 |
|
|
2025
Q1 | $62.7M | Buy |
865,619
+21,596
| +3% | +$1.55M | 0.01% | 710 |
|
|
2024
Q4 | $62.5M | Buy |
844,023
+81,144
| +11% | +$5.68M | 0.01% | 719 |
|
|
2024
Q3 | $50.3M | Sell |
762,879
-90,000
| -11% | -$6.54M | 0.01% | 801 |
|
|
2024
Q2 | $78.8M | Buy |
852,879
+30,655
| +4% | +$2.71M | 0.02% | 584 |
|
|
2024
Q1 | $78.6M | Buy |
822,224
+134,400
| +20% | +$11.3M | 0.02% | 583 |
|
|
2023
Q4 | $52.4M | Buy |
687,824
+19,893
| +3% | +$1.38M | 0.01% | 715 |
|
|
2023
Q3 | $46.3M | Sell |
667,931
-231,338
| -26% | -$18.6M | 0.01% | 712 |
|
|
2023
Q2 | $84.8M | Buy |
899,269
+37,382
| +4% | +$3.25M | 0.02% | 509 |
|
|
2023
Q1 | $71.3M | Sell |
861,887
-50,760
| -6% | -$3.99M | 0.02% | 554 |
|
|
2022
Q4 | $68.1M | Sell |
912,647
-114,414
| -11% | -$8.82M | 0.02% | 561 |
|
|
2022
Q3 | $84.9M | Sell |
1,027,061
-194,504
| -16% | -$18.7M | 0.03% | 447 |
|
|
2022
Q2 | $116M | Sell |
1,221,565
-146,801
| -11% | -$15.2M | 0.04% | 374 |
|
|
2022
Q1 | $161M | Sell |
1,368,366
-4,730
| -0.3% | -$531K | 0.04% | 339 |
|
|
2021
Q4 | $178M | Sell |
1,373,096
-2,809,638
| -67% | -$328M | 0.04% | 316 |
|
|
2021
Q3 | $474M | Sell |
4,182,734
-484,710
| -10% | -$55.3M | 0.1% | 189 |
|
|
2021
Q2 | $483M | Sell |
4,667,444
-141,498
| -3% | -$13.3M | 0.11% | 188 |
|
|
2021
Q1 | $402M | Sell |
4,808,942
-50,252
| -1% | -$4.25M | 0.09% | 213 |
|
|
2020
Q4 | $443M | Buy |
4,859,194
+243,707
| +5% | +$20.2M | 0.11% | 186 |
|
|
2020
Q3 | $368M | Buy |
4,615,487
+81,391
| +2% | +$6.35M | 0.1% | 190 |
|
|
2020
Q2 | $313M | Buy |
4,534,096
+610,303
| +16% | +$43.4M | 0.09% | 213 |
|
|
2020
Q1 | $247M | Buy |
3,923,793
+656,028
| +20% | +$47.3M | 0.09% | 222 |
|
|
2019
Q4 | $254M | Sell |
3,267,765
-283,992
| -8% | -$22.2M | 0.07% | 278 |
|
|
2019
Q3 | $260M | Sell |
3,551,757
-162,741
| -4% | -$11.4M | 0.07% | 258 |
|
|
2019
Q2 | $229M | Buy |
3,714,498
+381,480
| +11% | +$23.1M | 0.07% | 295 |
|
|
2019
Q1 | $213M | Sell |
3,333,018
-258,219
| -7% | -$14.7M | 0.06% | 306 |
|
|
2018
Q4 | $183M | Sell |
3,591,237
-51,957
| -1% | -$2.63M | 0.06% | 308 |
|
|
2018
Q3 | $211M | Sell |
3,643,194
-1,771,497
| -33% | -$86.6M | 0.06% | 314 |
|
|
2018
Q2 | $263M | Sell |
5,414,691
-1,296,516
| -19% | -$60.5M | 0.08% | 262 |
|
|
2018
Q1 | $312M | Sell |
6,711,207
-250,962
| -4% | -$10.9M | 0.09% | 218 |
|
|
2017
Q4 | $262M | Sell |
6,962,169
-682,677
| -9% | -$25.1M | 0.08% | 273 |
|
|
2017
Q3 | $279M | Buy |
7,644,846
+1,287,066
| +20% | +$49.1M | 0.09% | 236 |
|
|
2017
Q2 | $251M | Buy |
6,357,780
+744,879
| +13% | +$27.2M | 0.08% | 256 |
|
|
2017
Q1 | $176M | Buy |
5,612,901
+582,600
| +12% | +$18.2M | 0.06% | 336 |
|
|
2016
Q4 | $157M | Buy |
5,030,301
+2,590,638
| +106% | +$83.9M | 0.06% | 362 |
|
|
2016
Q3 | $98M | Buy |
2,439,663
+252,669
| +12% | +$9.52M | 0.04% | 513 |
|
|
2016
Q2 | $72.7M | Sell |
2,186,994
-1,516,233
| -41% | -$51.9M | 0.03% | 588 |
|
|
2016
Q1 | $109M | Buy |
3,703,227
+156,294
| +4% | +$4.31M | 0.04% | 441 |
|
|
2015
Q4 | $93.4M | Sell |
3,546,933
-356,823
| -9% | -$9.27M | 0.04% | 487 |
|
|
2015
Q3 | $92.5M | Buy |
3,903,756
+2,261,862
| +138% | +$54.6M | 0.04% | 490 |
|
|
2015
Q2 | $39M | Buy |
1,641,894
+633,684
| +63% | +$14.3M | 0.02% | 945 |
|
|
2015
Q1 | $23.9M | Buy |
1,008,210
+165,222
| +20% | +$3.71M | 0.01% | 1210 |
|
|
2014
Q4 | $17.9M | Buy |
842,988
+241,224
| +40% | +$4.85M | 0.01% | 1361 |
|
|
2014
Q3 | $10.2M | Buy |
601,764
+1,878
| +0.3% | +$29.6K | ﹤0.01% | 1759 |
|
|
2014
Q2 | $8.58M | Sell |
599,886
-692,676
| -54% | -$9.39M | ﹤0.01% | 1922 |
|
|
2014
Q1 | $16M | Buy |
1,292,562
+98,490
| +8% | +$1.14M | 0.01% | 1426 |
|
|
2013
Q4 | $13.1M | Sell |
1,194,072
-704,232
| -37% | -$7.94M | 0.01% | 1534 |
|
|
2013
Q3 | $22M | Buy |
1,898,304
+273,168
| +17% | +$3.2M | 0.01% | 1142 |
|
|
2013
Q2 | $18.2M | Buy |
+1,625,136
| New | +$19.2M | 0.01% | 1197 |
|
Other funds holding EW
VCM
VPM
Wells Fargo's EW Position: Q1 2026 in Review
Wells Fargo reduced its Edwards Lifesciences (EW) stake by 0.05% in Q1 2026, selling an estimated $47.9K and leaving 1,081,271 shares worth $86.6M. The position accounts for 0.02% of the portfolio, ranked #691.
Wells Fargo first reported a position in EW in Q2 2013 and has held it in 52 quarters since. The position peaked at $483M in Q2 2021. 1,283 funds tracked by Wall St. Rank hold EW as of Q1 2026.
- Wells Fargo held 1,081,271 shares of Edwards Lifesciences worth $86.6M as of Q1 2026.
- Wells Fargo sold 581 Edwards Lifesciences shares in Q1 2026, an estimated $47.9K.
- Edwards Lifesciences made up 0.02% of Wells Fargo's portfolio in Q1 2026, its #691 holding.
- Wells Fargo first reported a position in Edwards Lifesciences in Q2 2013 and has held it in 52 quarters since.
- Wells Fargo's Edwards Lifesciences position peaked at $483M in Q2 2021.
- 1,283 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2026.
Based on Wells Fargo's 13F filing for Q1 2026, filed 11 May 2026.